GADD45A and chronic myelogenous leukemia, BCR-ABL1 positive: Analysis of human CML samples revealed two distinct groups of chronic phase patients based on Gadd45a expression, where cohort I exhibited increased Gadd45a expression and cohort II exhibited reduced Gadd45a expression (Figure 7).